Provided by Tiger Trade Technology Pte. Ltd.

ENDRA Life Sciences Inc

4.49
-0.0950-2.07%
Post-market: 4.490.00000.00%19:30 EDT
Volume:27.44K
Turnover:121.78K
Market Cap:6.73M
PE:-0.71
High:4.70
Open:4.63
Low:4.19
Close:4.59
52wk High:9.85
52wk Low:2.96
Shares:1.50M
Float Shares:1.43M
Volume Ratio:1.35
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.2900
EPS(LYR):-8.9291
ROE:-152.04%
ROA:-77.32%
PB:1.07
PE(LYR):-0.50

Loading ...

Company Profile

Company Name:
ENDRA Life Sciences Inc
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
10
Office Location:
3600 Green Court,Suite 350,Ann Arbor,Michigan,United States
Zip Code:
48105-1570
Fax:
- -
Introduction:
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Directors

Name
Position
Alexander Tokman
Chief Executive Officer and Chairman
Anthony DiGiandomenico
Director
Louis J. Basenese
Director
Michael Harsh
Director

Shareholders

Name
Position
Alexander Tokman
Chief Executive Officer and Chairman
Richard Jacroux
Chief Financial Officer